Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses

Oncolytic viruses (OVs) preferentially infect and kill cancer cells. Additionally, OV-induced immune responses subvert cancer-associated immunosuppression and promote antitumor immunity. We have recently demonstrated that the complementation of oncolytic virotherapy with gemcitabine accentuates its...

Descripción completa

Detalles Bibliográficos
Autores principales: Gujar, Shashi A, Clements, Derek, Lee, Patrick WK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010537/
https://www.ncbi.nlm.nih.gov/pubmed/24804161
http://dx.doi.org/10.4161/onci.27622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010537/
https://www.ncbi.nlm.nih.gov/pubmed/24804161
http://dx.doi.org/10.4161/onci.27622

Ejemplares similares